Loading stock data...

Trident Lifeline Limited

BSE: TLL

BSE
258.00 -17.90 (-6.49%)

Prev Close

275.9

Open Price

260

Volume

3,600

Today Low / High

256 / 264.95

52 WK Low / High

222 / 328

Range

245 - 271

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 258, reflecting a change of -17.9 (-6.48786%). The expected target range on the BSE is 245 - 271. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 260.00 -0.77%
24 Feb 275.90 0.00%
23 Feb 263.00 -3.42%
20 Feb 268.95 -2.27%
19 Feb 255.00 0.41%
18 Feb 277.00 -7.76%
17 Feb 270.00 -6.59%
16 Feb 268.20 -1.19%
13 Feb 274.00 1.81%
12 Feb 263.00 6.08%
11 Feb 272.00 0.02%
10 Feb 294.00 -2.24%
09 Feb 286.00 -1.05%
05 Feb 296.40 0.00%
03 Feb 300.00 -3.25%
02 Feb 299.95 1.02%
30 Jan 297.25 0.00%
29 Jan 288.60 1.18%
28 Jan 295.00 -2.17%

Trident Lifeline Limited Graph

Trident Lifeline Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Trident Lifeline Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 258.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 258.00 260.58 234.52 - 286.64
263.16 210.53 - 315.79
265.74 186.02 - 345.46
Bearish Scenario 258.00 255.42 229.88 - 280.96
252.84 202.27 - 303.41
250.26 175.18 - 325.34

Overview of Trident Lifeline Limited

ISIN

INE0MKA01014

Industry

Medical - Pharmaceuticals

Vol.Avg

14,389

Market Cap

3,078,714,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2022-10-06

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for TLL

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 86.96 Cr 68.16 Cr 41.41 Cr 0.4762 0.45 Cr 0.00 Cr 9.37 Cr 11.75 Cr 10.22 23.09 Cr 0.1351
2024-03-31 44.63 Cr 32.07 Cr 12.56 Cr 0.2814 0.04 Cr 0.75 Cr 8.07 Cr 6.34 Cr 5.52 10.27 Cr 0.1421
2023-03-31 31.69 Cr 22.58 Cr 9.12 Cr 0.2876 0.02 Cr 0.54 Cr 6.19 Cr 6.02 Cr 6.23 7.41 Cr 0.1898
2022-03-31 21.77 Cr 18.17 Cr 3.60 Cr 0.1654 0.02 Cr 0.67 Cr 2.58 Cr 3.95 Cr 6.92 3.31 Cr 0.1814
2021-03-31 9.62 Cr 7.63 Cr 1.99 Cr 0.2070 0.00 Cr 0.30 Cr 1.11 Cr 0.63 Cr 0.55 1.41 Cr 0.0657

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.46 Cr 156.01 Cr 86.36 Cr 64.4564 Cr 54.03 Cr 51.57 Cr 28.24 Cr 36.52 Cr 0.00 Cr 0.00 Cr 10.72 Cr 53.5547 Cr
2024-03-31 6.65 Cr 87.08 Cr 33.13 Cr 52.8965 Cr 18.41 Cr 11.76 Cr 12.58 Cr 20.37 Cr 4.31 Cr 0.00 Cr 3.77 Cr 20.2562 Cr
2023-03-31 13.78 Cr 62.57 Cr 15.46 Cr 45.6350 Cr 7.69 Cr -6.09 Cr 7.17 Cr 5.35 Cr 1.19 Cr 0.00 Cr 3.34 Cr 11.5340 Cr
2022-03-31 0.16 Cr 13.83 Cr 9.06 Cr 4.7757 Cr 2.45 Cr 2.30 Cr 3.71 Cr 0.31 Cr 0.35 Cr 0.00 Cr 0.00 Cr 7.5698 Cr
2021-03-31 0.09 Cr 11.44 Cr 11.91 Cr -0.4707 Cr 4.53 Cr 4.43 Cr 5.30 Cr 0.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 7.3372 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -10.2417 Cr -13.8247 Cr 19.7605 Cr -22.6992 Cr -4.1938 Cr 2.4605 Cr 0.0000 Cr 0.0000 Cr 23.6577 Cr 0.0000 Cr -7.8385 Cr
2024-03-31 3.0771 Cr -21.8201 Cr 11.6126 Cr -14.8141 Cr -7.1250 Cr 6.6543 Cr -17.8912 Cr 6.3439 Cr 10.6177 Cr 0.0000 Cr -5.4157 Cr
2023-03-31 -18.7109 Cr -10.4421 Cr 42.7487 Cr -25.6349 Cr 13.6228 Cr 13.7793 Cr -6.9240 Cr 6.5825 Cr 5.9868 Cr 0.0000 Cr -3.4563 Cr
2022-03-31 -0.3405 Cr -0.4452 Cr 0.9277 Cr -0.7957 Cr 0.1420 Cr 0.1566 Cr -0.4552 Cr 2.9836 Cr -2.6673 Cr 0.0000 Cr 1.5594 Cr
2021-03-31 1.4846 Cr -0.5563 Cr -0.9584 Cr 0.5235 Cr -0.0303 Cr 0.0935 Cr -0.5577 Cr 0.8539 Cr -1.9370 Cr 0.0000 Cr -4.3350 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 25.71 Cr 20.05 Cr 5.66 Cr 0.2203 2.63 Cr 4.30 Cr 3.61 9.72 Cr 0.1674
2025-09-30 31.34 Cr 22.43 Cr 8.90 Cr 0.2842 5.95 Cr 4.95 Cr 4.27 8.53 Cr 0.1579
2025-06-30 23.61 Cr 10.95 Cr 12.66 Cr 0.5363 3.71 Cr 3.06 Cr 2.66 6.52 Cr 0.1297
2025-03-31 46.05 Cr 38.82 Cr 7.22 Cr 0.1568 -0.29 Cr 3.82 Cr 3.33 10.02 Cr 0.0830
2024-12-31 11.83 Cr 3.72 Cr 8.10 Cr 0.6852 3.47 Cr 2.79 Cr 2.42 4.64 Cr 0.2357

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 2.63 Cr 0.00 Cr 2.63 Cr 40.09 Cr 34.28 Cr 119.64 Cr 37.57 Cr 186.86 Cr 100.41 Cr
2025-06-30 0.00 Cr 0.00 Cr 2.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -69.65 Cr
2025-03-31 2.46 Cr 0.00 Cr 2.46 Cr 27.68 Cr 28.24 Cr 90.37 Cr 36.52 Cr 156.01 Cr 86.36 Cr
2024-12-31 0.00 Cr 0.00 Cr 6.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -57.62 Cr
2024-09-30 6.57 Cr 0.00 Cr 6.57 Cr 19.83 Cr 13.02 Cr 61.33 Cr 21.24 Cr 97.86 Cr 40.24 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 2.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 3.82 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 2.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 3.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Chief Financial Officer & Director
Ashish Anandsingh Bafna

Gender: male

Year Born: 1975

Executive Chairman
Hardik Jigishkumar Desai

Gender: male

Year Born: 1978

MD & Executive Director
Shravan Harikrishna Patel

Gender: male

Year Born: 1994

Company Secretary & Compliance officer
Nikita Sharma

Gender: female

Year Born:

Whole-Time Executive Women Director
Rupaben Chetankumar Jariwala

Gender: female

Year Born:

FAQs about Trident Lifeline Limited

Who is the CEO of the company?

The CEO is Hardik Jigishkumar Desai.

What is the current market price of the stock?

The current price is ₹258.00.

What is the 52-week price range?

The range is ₹222-328.

What is the market capitalization of the company?

The market capitalization is ₹307.87 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 19.08.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Trident Lifeline Limited (ISIN: INE0MKA01014) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹307.87 crores and an average daily volume of 14,389 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.